Camurus, a Lund-based Swedish biopharmaceutical company renowned for its innovative FluidCrystal technology that encapsulates drugs in lipid nanostructures for sustained release via single injections, discovered unexpected benefits from Revvity Signals Notebook. The electronic lab notebook enhanced data management for complex formulations targeting pain and addiction therapies, improving documentation accuracy, collaboration across development stages, workflow efficiency, and regulatory readiness. This supported Camurus's impressive innovation track record, accelerating progress from research to successful product applications.

Join for free to read